HomeORGANIZATION
ORGANIZATION

Continued Discussions Needed for PMP-Eligible Products, Company Criteria: FPMAJ/JPMA
(Dec.22.2017)

Key Japanese pharma industry organizations on December 20 called for continued discussions on the scope of eligible products newly adopted for the so-called price maintenance premium (PMP), as well as new company requirements that would limit the number of drug makers obtaining a full price maintenance ...
(LOG IN FOR FULL STORY)

News Calendar